<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02390895</url>
  </required_header>
  <id_info>
    <org_study_id>P141202</org_study_id>
    <secondary_id>2014-A01948-39</secondary_id>
    <nct_id>NCT02390895</nct_id>
  </id_info>
  <brief_title>Prenatal Endoscopic Repair of Fetal Spina Bifida</brief_title>
  <acronym>ENDOSPIN</acronym>
  <official_title>Prenatal Endoscopic Repair of Fetal Spina Bifida</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the feasibility of prenatal minimally-invasive
      fetoscopic closure with i) uterine exteriorization for a minimally-invasive repair under
      amniotic carbon dioxide insufflation ii) two trocars for the dissection and the cover with
      one patch or the suture of the skin edges by stitch
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compared with an open approach involving laparotomy and hysterotomy, an endoscopic approach
      for the prenatal surgery of myelomeningocele offers at least two potential advantages: i) it
      may reduce the maternal and obstetric morbidity related to the hysterotomy; ii) it may be
      performed earlier in gestation than open surgery, therefore potentially further reducing
      exposition of the spinal chord to the intraamniotic environment and thus improving the
      overall prognosis of the malformation. This study aims to evaluate the feasibility and
      potential benefits of a minimally invasive endoscopic procedure for the prenatal treatment of
      myelomeningocele in a single-center trial.

      Technically the procedure will be performed through 2 intra-amniotic ports, under fetoscopic
      visualization and intra-amniotic carbon dioxide insufflation. The defect will be dissected
      and the cord replaced in the canal. Closure will be performed by suturing paravertebral
      muscles using a barbed running suture. A Duragen patch will be sutured when primary closure
      is deemed impossible.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2017</start_date>
  <completion_date type="Anticipated">March 16, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>successful surgery</measure>
    <time_frame>Before 26 gestational weeks</time_frame>
    <description>Composite criteria:
dissection of the placode
primary coverage or use of a patch
using only endoscopy with two trocars</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neonatal surgery</measure>
    <time_frame>Day 0 (birth of neonates)</time_frame>
    <description>Need for neonatal surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arnold Chiari anomaly at birth</measure>
    <time_frame>Day 0 (birth of neonates)</time_frame>
    <description>the existence of an Arnold Chiari anomaly at birth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventriculo-peritoneal shunt</measure>
    <time_frame>Within the 6 months after birth</time_frame>
    <description>Ventriculo-peritoneal shunt within the 6 months after birth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of injury</measure>
    <time_frame>Within the 6 months after birth</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Foetal</measure>
    <time_frame>From surgery to delivery</time_frame>
    <description>Composite criteria:
Stillbirth Premature Rupture of Membranes Preterm birth Chorioamnionitis Hemorrhagic complications during the peri-operative period Other serious adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>motor lower limb improvement outcomes</measure>
    <time_frame>Within the 6 months after birth</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>maternal morbidity</measure>
    <time_frame>From surgery to delivery</time_frame>
    <description>Composite criteria:
Stillbirth Premature Rupture of Membranes Preterm birth Chorioamnionitis Hemorrhagic complications during the peri-operative period Other serious adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurological development</measure>
    <time_frame>36 months</time_frame>
    <description>Composite criteria:
Motor deficit medullary reflex orthopedic anomalies consequences on perinea and sphincter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WPPSI-III (Wechsler Preschool and Primary Scale of Intelligence) :evaluation of intellectual quotient</measure>
    <time_frame>36 months</time_frame>
    <description>Neurodevelopment outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brunet-Lezine Psychomotor Development Scale</measure>
    <time_frame>36 months</time_frame>
    <description>Psychomotor and Development outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Myelomeningocele</condition>
  <arm_group>
    <arm_group_label>Minimally-invasive endoscopic repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>endoscopic repair of myelomeningocele before 26 SA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>surgery at birth</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Non eligible pregnant women because of foetal or maternal reasons or women refusing the prenatal surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endoscopic repair of myelomeningocele before 26 SA</intervention_name>
    <description>prenatal minimally-invasive fetoscopic closure with iii) uterine exteriorization for a minimally-invasive repair under amniotic carbon dioxide insufflation iv) two trocars for the dissection and the cover with one patch or the suture of the skin edges by stitch</description>
    <arm_group_label>Minimally-invasive endoscopic repair</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Postnatal Myelomeningocele Repair Surgery</intervention_name>
    <description>repair of myleomeningocele after birth</description>
    <arm_group_label>surgery at birth</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient &gt; 18 years old, with an assumption by health insurance, understanding and
             speaking French

          -  A term before 26 +0 weeks gestational age

          -  Single-Pregnancy

          -  Myelomeningocele with higher-level defect between S1 and T1

          -  Arnold Chiari anomaly

          -  No associated anomaly or chromosic anomaly

          -  Normal fetal karyotype or FISH

        Exclusion Criteria:

          -  severe foetal kyphoscoliosis associated

          -  Increased risk of preterm birth: cervical length &lt;15 mm, history of at least 2 late
             miscarriages, existing premature rupture of membrane

          -  placenta previa, accreta or placental abruption

          -  Maternal obesity with BMI&gt; 35

          -  Uterine anomalies : large interstitial uterine fibroid, uterine malformation

          -  maternal infection with a foetal transmission risk: HIV, HBV, HCV Maternal
             contradiction in surgery or anesthesia

          -  poor social status and/or social isolation

          -  impossible post-surgery follow-up

          -  want to have a medical pregnancy termination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves Ville, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yves Ville, PUPH</last_name>
    <phone>01 71 39 65 13</phone>
    <email>ville.yves@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nelly Briand, PhD</last_name>
    <phone>+33 1 44 38 18 62</phone>
    <email>nelly.briand@nck.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Ville, PUPH</last_name>
      <phone>01 71 39 65 13</phone>
      <email>ville.yves@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Laurence Lecomte, PhD</last_name>
      <phone>+33 1 71 19 64 94</phone>
      <email>laurence.lecomte@nck.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Julien STIRNEMANN, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Kohl T. Percutaneous minimally invasive fetoscopic surgery for spina bifida aperta. Part I: surgical technique and perioperative outcome. Ultrasound Obstet Gynecol. 2014 Nov;44(5):515-24. doi: 10.1002/uog.13430.</citation>
    <PMID>24891102</PMID>
  </reference>
  <reference>
    <citation>Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011 Mar 17;364(11):993-1004. doi: 10.1056/NEJMoa1014379. Epub 2011 Feb 9.</citation>
    <PMID>21306277</PMID>
  </reference>
  <reference>
    <citation>Degenhardt J, Schürg R, Winarno A, Oehmke F, Khaleeva A, Kawecki A, Enzensberger C, Tinneberg HR, Faas D, Ehrhardt H, Axt-Fliedner R, Kohl T. Percutaneous minimal-access fetoscopic surgery for spina bifida aperta. Part II: maternal management and outcome. Ultrasound Obstet Gynecol. 2014 Nov;44(5):525-31. doi: 10.1002/uog.13389.</citation>
    <PMID>24753062</PMID>
  </reference>
  <reference>
    <citation>Verbeek RJ, Heep A, Maurits NM, Cremer R, Hoving EW, Brouwer OF, van der Hoeven JH, Sival DA. Fetal endoscopic myelomeningocele closure preserves segmental neurological function. Dev Med Child Neurol. 2012 Jan;54(1):15-22. doi: 10.1111/j.1469-8749.2011.04148.x. Epub 2011 Nov 29. Review.</citation>
    <PMID>22126123</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2015</study_first_submitted>
  <study_first_submitted_qc>March 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2015</study_first_posted>
  <last_update_submitted>April 13, 2018</last_update_submitted>
  <last_update_submitted_qc>April 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Minimally-invasive endoscopic repair</keyword>
  <keyword>fetal surgery</keyword>
  <keyword>outcome</keyword>
  <keyword>Foetus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Dysraphism</mesh_term>
    <mesh_term>Meningomyelocele</mesh_term>
    <mesh_term>Spina Bifida Cystica</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

